Apria Healthcare Llc Durable Medical Equipment & Medical Supplies Location: 1075 Martha Glass Dr, Jefferson City, Tennessee 37760 Phone: (865) 475-8953 |
Jeremy L Diamond Eyewear Supplier (Equipment, not the service) Location: 741 E Broadway Blvd, Jefferson City, Tennessee 37760 Phone: (865) 475-8680 |
Food City Pharmacy #615 Durable Medical Equipment & Medical Supplies Location: 1507 Odell Ave, Jefferson City, Tennessee 37760 Phone: (865) 471-0366 |
Mcfarland Group, Inc. DME Supplier - Oxygen Equipment & Supplies Location: 665 E Broadway Blvd, Jefferson City, Tennessee 37760 Phone: (865) 229-1497 |
Cvs Pharmacy #03769 Durable Medical Equipment & Medical Supplies Location: 139 E Broadway Blvd, Jefferson City, Tennessee 37760 Phone: (865) 475-6702 |
Walmart Pharmacy 10-0724 Durable Medical Equipment & Medical Supplies Location: 630 E Broadway Blvd, Jefferson City, Tennessee 37760 Phone: (865) 475-3736 |
Walgreens #9430 Durable Medical Equipment & Medical Supplies Location: 132 E Broadway Blvd, Jefferson City, Tennessee 37760 Phone: (865) 471-0548 |
News Archive
The case of Sen. Edward Kennedy (D-Mass.), who has been diagnosed with brain cancer, is "identical from a regulatory standpoint to the plight of hundreds of thousands of other Americans" and "shouts to the heavens the humane necessity of urgent reform in the drug approval process to make it work better for people who have serious and terminal diseases," according to a Wall Street Journal opinion piece by Steven Walker and Ronald Trowbridge, chief adviser and adjunct scholar, respectively, of the Abigail Alliance for Better Access to Developmental Drugs.
Serum hepatitis B core-related antigen could serve as a quantitative marker of response to pegylated interferon therapy in patients with chronic hepatitis B virus infection positive for hepatitis B e antigen (HBeAg), findings indicate.
Depressive symptoms and pain in patients on dialysis may have serious negative consequences for patients' health and increase the need for costly medical services, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
A blood vessel-blocking drug called tasquinimod slowed the rate of disease progression in a clinical trial of 200 prostate cancer patients, according to experts at Johns Hopkins, Roswell Park Cancer Institute and Duke University.
› Verified 5 days ago